ArticleMedical science monitor : international medical journal of experimental and clinical research2016

Isoflurane Promotes Non-Small Cell Lung Cancer Malignancy by Activating the Akt-Mammalian Target of Rapamycin (mTOR) Signaling Pathway.

Wenhua Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.